Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.

Gridelli, C

Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) Dec 1995 - 2424-6 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Letter

0959-8049

10.1016/0959-8049(95)00403-3 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carboplatin--administration & dosage
Carcinoma, Small Cell--drug therapy
Carmustine--administration & dosage
Cyclophosphamide--administration & dosage
Epirubicin--administration & dosage
Etoposide--administration & dosage
Female
Granulocyte Colony-Stimulating Factor--therapeutic use
Humans
Lung Neoplasms--drug therapy
Male
Middle Aged